Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Interim Statements of Cash Flows (Unaudited)

v3.21.2
Condensed Consolidated Interim Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities    
Loss for the period $ (5,966) $ (19,518)
Adjustments to reconcile net loss to net cash used in operating activities    
Amortization of intangible assets   1
Depreciation of property and equipment 15  
In-process research and development 16,094 16,094
Change in fair value of milestone liability (3)  
Interest expense   8
Amortization of deferred loan costs   27
Warrants issued for services 31 45
Stock option expense 811 405
Changes in operating assets and liabilities    
Prepaid expenses, deposits and other (13) 24
Accounts payable and accrued liabilities 122 (914)
Related party payables (70) (282)
Net cash used in operating activities (5,073) (4,110)
Cash flows from investing activities    
Cash acquired on merger with Adgero   969
Net cash provided by investing activities   969
Cash flows from financing activities    
Net proceeds from the issuance of shares and warrants 13,803 21,859
Warrants exercised for cash 74 994
Proceeds from loan   500
Series A preferred cash dividend (2) (2)
Net cash provided by financing activities 13,875 23,351
Increase in cash and cash equivalents 8,802 20,210
Cash and cash equivalents – beginning of period 10,537 2,392
Cash and cash equivalents – end of period $ 19,339 $ 22,602